Measuring what matters MOST: Validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer (ROC)

King, MT; Stockler, M; O'Connell, R; Buizen, L; Joly, F; Lanceley, A; Hilpert, F; ... Friedlander, M; + view all King, MT; Stockler, M; O'Connell, R; Buizen, L; Joly, F; Lanceley, A; Hilpert, F; Okamato, A; AOTANI, E; Bryce, J; Donnellan, P; Oza, A; Avall-Lundquist, M; Berek, J; Feeney, A; Berton-Rigaud, D; Sehouli, J; Friedlander, M; - view fewer (2018) Measuring what matters MOST: Validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer (ROC). Quality of Life Research , 27 (1) pp. 59-74. 10.1007/s11136-017-1729-8 .

https://ift.tt/2uS8ou3